Back to search

Article

Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, Against SARS-CoV-2 Challenge in Nonhuman Primates

2023-09-20

Abstract excerpt

TNX-1800 is a synthetically derived live chimeric Horsepox Virus (rcHPXV) vaccine expressing Wuhan SARS-CoV-2 spike (S) protein. The primary objective of this study was to evaluate the immunogenicity and efficacy of TNX-1800 in two nonhuman primate species challenged with USA-WA1/2020 SARS-CoV-2. TNX-1800 vaccination was well tolerated, as indicated by the lack of serious adverse events or significant changes in c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b49a77f6-5870-5a02-81bd-497964084b6c
DOI
10.1101/2023.09.19.558485
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, Against SARS-CoV-2 Challenge in Nonhuman PrimatesDOI 10.1101/2023.09.19.558485
Synthetic modified vaccinia Ankara vaccines confer potent monkeypox immunity in non-human primates and healthy adultsSemantic proximity
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaquesSemantic proximity
DNA vaccine protection against SARS-CoV-2 in rhesus macaquesSemantic proximity
Intranasal Pediatric Parainfluenza Virus-Vectored SARS-CoV-2 Vaccine Candidate Is Protective in MacaquesSemantic proximity
JYNNEOS VS. ACAM2000: A CRITICAL REVIEW OF THE SAFETY, EFFICACY AND REAL-WORLD EFFECTIVENESS OF MONKEYPOX VACCINESSemantic proximity
Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic developmentSemantic proximity
Mucosal Immunization of Cynomolgus Macaques with Adenoviral Vector Vaccine Elicits Neutralizing Nasal and Serum Antibody to Several SARS-CoV-2 VariantsSemantic proximity
Recombinant chimeric Horsepox Virus (TNX-801) is attenuated relative to Vaccinia Virus Strains in Human Primary Cell Lines and in Immunocompromised MiceSemantic proximity
Non-replicating vaccinia virus NTV as an effective next-generation smallpox and monkeypox vaccine: evidence from mouse and rhesus monkey modelsSemantic proximity
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primatesSemantic proximity
Development of a live attenuated vaccine candidate for equid alphaherpesvirus 1 control: a step towards efficient protection.Semantic proximity
Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virusSemantic proximity
Select a neighboring publication to make it the new centre.